Table 2

The median of differences in titre of anti-mutated citrullinated vimentin IgG (A MCV IgG), anti-citrullinated peptide of vimentin IgG (A P18 IgG), anti-carbamylated peptide of vimentin IgG (A HC52 IgG) and rheumatoid factor IgM (RF IgM) from baseline to 24 and 48 weeks after therapy in responder group of patients with rheumatoid arthritis (RA)

Embedded Image
  • The analysis was done in relation to their achieved DAS28 response after 24 weeks of treatment. Paired sample sign test was used and statistical significance is indicated for p<0.05 (*), p<0.01 (**) and p<0.001 (***).

  • DAS28, disease activity score 28.